Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05528107
Other study ID # 2907-1/22
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 14, 2023
Est. completion date March 2024

Study information

Verified date March 2023
Source City Clinical Hospital No.1 named after N.I. Pirogov
Contact Alexander Sazhin, professor
Phone +79163904180
Email sazhin-av@yandex.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The survey will compare primary and secondary outcomes of laparoscopic intraperitoneal onlay mesh (IPOM plus) and extended totally extraperitoneal (eTEP) repair for incisional hernia. The research hypothesis is the following: patients who underwent eTEP repair may experience 30% less pain, assessed on the NRS-11 scale by the end of postoperative day 1, compared with IPOM plus procedure


Description:

The use of minimally invasive surgery for the treatment of patients with incisional ventral hernias has significant advantages over open surgery. According to the current guidelines, the optimal technique for IPOM repair is a combination of suturing hernia defect and implantation an intraperitoneal anti-adhesive coated mesh prosthesis - the so-called "IPOM plus" technology (R.Bittner et al., 2019). The development of laparoscopic surgery has led to the new minimally invasive technique for ventral hernia repair - extended-view totally extraperitoneal plasty (eTEP) (I. Belyansky et al., 2018). An important advantage of eTEP is the non-fixation technique of implant placement due to correct positioning compared to the need for combined fixation for IPOM or IPOM plus, which probably affects on the level of postoperative pain in the early postoperative period. The results of the first RCT comparing IPOM and eTEP ventral hernia repair were recently published (Mayank J. et al., 2022). It was demonstrated the benefits of eTEP repair in several aspects: less pain in the early postoperative period, as well as a faster return to physical activity and lower intervention costs. However, a significant limitation of this RCT is the analysis of interventions in a mixed group of patients with primary ventral and incisional hernias, as well as the use of IPOM procedure without suturing the hernia defect. The sample size was determined based on the above hypothesis regarding the primary point of the study. Considering trial of Asencio F. et al. (2009) in a group of patients with incisional ventral hernias, the level of pain at the end of the first postoperative day after IPOM repair was 4.76 according to the VAS (visual analog scale) with a standard deviation of 1.975. Assuming α (type I error rate) 0.05, β 0.20, it would need a total sample size of 60 patients. Taking into account the probability of loss of patients in the evaluation of long-term results up to 20%, 72 patients will be required (36 patients per group). Taking into account the inconsistency of the literature data on the level of pain in the early postoperative period after IPOM procedure for incisional ventral hernia repair, as well as the established primary point of the study, the investigators plan an additional calculation with correction of the sample size after evaluation intermediate results upon reaching 50% of enrolled patients of the initially established.


Recruitment information / eligibility

Status Recruiting
Enrollment 72
Est. completion date March 2024
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - midline incisional hernia - defect width 2-6 cm - ASA I-II class - Elective hernia repair - Considered eligible for minimally invasive ventral hernia repair - Able to give informed consent - Able to tolerate general anesthesia Exclusion Criteria: - primary ventral herna - lateral hernia with/without midline - defect width more than 6 cm - refuse to give informed consent - prior mesh placement in the retrorectus space

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Lap IPOM plus
Participants will undergo Lap IPOM plus repair according to the assigned treatment arm.
eTEP
Participants will undergo eTEP repair according to the assigned treatment arm.

Locations

Country Name City State
Russian Federation Clinical City Hospital #1 named after N.I. Pirogov Moscow

Sponsors (2)

Lead Sponsor Collaborator
City Clinical Hospital No.1 named after N.I. Pirogov Pirogov Russian National Research Medical University

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain on postoperative day 1 Pain score will be assessed using the Numeric Pain Rating Scale. The mean pain score is calculated between pain values at rest and on coughing.
Participants verbally requested to rate their pain : "Rate your pain from 0 (no pain) to 10 (unbearable pain)". 0 point is the minimum and 10 point is the maximum. The higher the score, the more severe the pain.
postoperative day 1
Secondary pain on postoperative days 7 and 30 Pain score will be assessed using the Numeric Pain Rating Scale. The mean pain score is calculated between pain values at rest and on physical activity.
Participants verbally requested to rate their pain : "Rate your pain from 0 (no pain) to 10 (unbearable pain)". 0 point is the minimum and 10 point is the maximum. The higher the score, the more severe the pain.
postoperative 7 (±1) and 30 (±3) days
Secondary number of participants with chronic pain Persisted pain in surgical site more than 90 days after surgery. Pain score will be assessed using the Numeric Pain Rating Scale. Participants verbally requested to rate their pain : "Rate your pain from 0 (no pain) to 10 (unbearable pain)". 0 point is the minimum and 10 point is the maximum. The higher the score, the more severe the pain. postoperative day 100 (±5 days)
Secondary length of stay From date of hospital admission until discharge. The length of hospital stay (days) 30 days after surgery
Secondary postoperative complications Number of participants with postoperative complications, evaluated by Clavien-Dindo classification of surgical complications from Dindo et al. 30 days after surgery
Secondary analgetic consumption Consumption of analgesics during the first 48 hours after surgery 48 hours after surgery
Secondary pain 6 hours after surgery Pain score will be assessed using the Numeric Pain Rating Scale. The mean pain score is calculated between pain values at rest and on coughing.
Participants verbally requested to rate their pain : "Rate your pain from 0 (no pain) to 10 (unbearable pain)". 0 point is the minimum and 10 point is the maximum. The higher the score, the more severe the pain.
6 hours (± 1 hour) after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05424484 - Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence N/A
Not yet recruiting NCT06195332 - Open vs. Endoscopic Transversus Abdominis Release Trial N/A
Recruiting NCT04808063 - Algorithm for Prophylactic Mesh Use in Emergency Laparotomy. N/A
Recruiting NCT04358159 - RCT Ventralex vs Onlay Mesh in Incisional Hernias N/A
Completed NCT05351970 - Barbed Suture for Emergency Midline Laparotomy Closure
Completed NCT04166201 - Double Mesh Modification of Incisional Hernia Can be Effective Without Severe Local Complications N/A
Not yet recruiting NCT06286124 - Midline Restoration After HYbriD Hernia RepAir Surgery (HYDRA)